Paloma Partners’s GSK GSK Stock Holding History

Paloma Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,802	Closed	-$207K	–	1359
2022 Q1	$207K	Buy	+3,802	New	+$207K	0.01%	1378
2020 Q1	–	Sell	-4,479	Closed	-$263K	–	1564
2019 Q4	$263K	Sell	4,479 -12,981	-74%	-$722K	﹤0.01%	1833
2019 Q3	$931K	Buy	+17,460	New	+$898K	0.02%	781
2019 Q2	–	Sell	-13,256	Closed	-$692K	–	1916
2019 Q1	$692K	Buy	+13,256	New	+$662K	0.02%	913
2017 Q2	–	Sell	-10,402	Closed	-$549K	–	2279
2017 Q1	$549K	Buy	10,402 +2,482	+31%	+$126K	0.01%	1551
2016 Q4	$381K	Buy	+7,920	New	+$391K	﹤0.01%	1625
2016 Q3	–	Sell	-7,938	Closed	-$430K	–	1945
2016 Q2	$430K	Buy	+7,938	New	+$418K	﹤0.01%	1604

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Paloma Partners's GSK Position: Q2 2022 in Review

Paloma Partners sold out of GSK (GSK) in Q2 2022, closing a stake of 3,802 shares — an estimated $207K sold.

Paloma Partners first reported a position in GSK in Q2 2016 and held it in 7 quarters. The position peaked at $931K in Q3 2019. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Paloma Partners reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 3,802 GSK shares in Q2 2022, an estimated $207K.
Paloma Partners first reported a position in GSK in Q2 2016 and held it in 7 quarters.
Paloma Partners's GSK position peaked at $931K in Q3 2019.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.